Vistriterpenoids A and B, Two New 24-Nor-oleanane Triterpenoids from Dodonaea viscosa-Reference-Cited by-同舟云学术

Vistriterpenoids A and B, Two New 24-Nor-oleanane Triterpenoids from Dodonaea viscosa

Published:2018-10-31 Issue:11 Volume:15 Page:e1800426
ISSN:1612-1872
Container-title:Chemistry & Biodiversity
language:en
Short-container-title:C&B

Author:

Wang Xiao-Hang¹,Zhu Ke-Xin²³,Li Jing-Ya²,Lei Chun¹,Hou Ai-Jun¹

Affiliation:

1. Department of Pharmacognosy; School of Pharmacy; Fudan University; Shanghai 201203 P. R. China

2. State Key Laboratory of Drug Research; the National Center for Drug Screening; Shanghai Institute of Materia Medica; Chinese Academy of Sciences; Shanghai 201203 P. R. China

3. University of Chinese Academy of Sciences; No.19 A Yuquan Road Beijing 100049 P. R. China

Funder

The National Natural Science Foundation of China

National Key Research and Development Program of China

Shanghai Commission of Science and Technology

Publisher

Wiley

Subject

Molecular Biology,Molecular Medicine,General Chemistry,Biochemistry,General Medicine,Bioengineering

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cbdv.201800426/fullpdf

Reference19 articles.

1. Dodonaea viscosa Tetrahedron 2001 57

2. Dodonaea polyandra Phytochemistry 2011 72

3. Dodonaea viscosa J. Nat. Prod 2009 72

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oleanane triterpenoids with PTP1B and α -glucosidase inhibitory activities from Caulophyllum robustum;Natural Product Research;2024-06-20

2. Triterpenoids and saponins in drug discovery;Privileged Scaffolds in Drug Discovery;2023

3. Peculiarities of the distribution of assimilates in the organs of Schisandra chinensis plants under different soil and climatic conditions;Biosystems Diversity;2022-11-11

4. Targeted Inhibition of Protein Tyrosine Phosphatase 1B by Viscosol Ameliorates Type 2 Diabetes Pathophysiology and Histology in Diabetic Mouse Model;BioMed Research International;2022-08-22

5. Recent updates on development of protein-tyrosine phosphatase 1B inhibitors for treatment of diabetes, obesity and related disorders;Bioorganic Chemistry;2022-04